# CSL opens $230M albumin manufacturing facility in Broadmeadows, Victoria

CSL Limited opened a new $230 million advanced manufacturing facility at its CSL Behring site in Broadmeadows, Victoria. The facility will expand CSL's albumin capabilities to 200 tonnes annually and export to the US, Europe, and Asia Pacific.

- Type: New facility
- Announced: 2017-12-08
- Where: Broadmeadows, Victoria, Australia
- Value: $230.0M
- Starts operating: 8 Dec 2017
- Status: completed
- Capacity: 200 tonnes annually
- Products: albumin
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [CSL](https://endata.com/companies/3244.md)

## Sources

- [pharmacydaily.com.au](https://pharmacydaily.com.au/news/new-csl-facility/69746), 2017-12-07: "CSL Limited has opened a new $230 million advanced manufacturing facility at its CSL Behring site in Broadmeadows, Vic."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.